Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Non Operating Income: 2019-2025

Historic Non Operating Income for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to $3.8 million.

  • Benitec Biopharma's Non Operating Income rose 24.28% to $1.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.8 million, marking a year-over-year increase of 420.70%. This contributed to the annual value of $3.8 million for FY2025, which is 420.70% up from last year.
  • Latest data reveals that Benitec Biopharma reported Non Operating Income of $3.8 million as of FY2025, which was up 420.70% from $739,000 recorded in FY2024.
  • In the past 5 years, Benitec Biopharma's Non Operating Income ranged from a high of $3.8 million in FY2025 and a low of -$481,000 during FY2023.
  • For the 3-year period, Benitec Biopharma's Non Operating Income averaged around $1.4 million, with its median value being $739,000 (2024).
  • As far as peak fluctuations go, Benitec Biopharma's Non Operating Income slumped by 941.18% in 2021, and later surged by 420.70% in 2025.
  • Benitec Biopharma's Non Operating Income (Yearly) stood at -$286,000 in 2021, then declined by 23.78% to -$354,000 in 2022, then slumped by 35.88% to -$481,000 in 2023, then soared by 253.64% to $739,000 in 2024, then spiked by 420.70% to $3.8 million in 2025.